Abstract
Introduction

The nuclear factor-B (NF-B) transcription factor family regulates the expression of multiple genes that are involved in inflammation, immunity, differentiation, proliferation and apoptosis. In mammals, the NF-B family consists of five members
, which function as homo-or heterodimers [1] .
Each possesses an N-terminal Relhomology domain that is responsible for dimerization, nuclear translocation and DNA binding. The most common heterodimer is p50/p65, which is kept inactive in the cytoplasm by binding to the inhibitor of B (IB) ␣ protein. p50/p65 is activated in response to IB kinase (IKK) ␤-mediated phosphorylation of IB␣, which triggers its ubiquitination and subsequent proteasome-mediated degradation, thereby releasing NF-B to translocate to the nucleus and bind to the promoter of NF-B responsive genes.
In the nucleus, NF-B itself can also be phosphorylated by different kinases, which further regulate its transcriptional activation potential [1, 2] . [3] . [4, 5] [7] [8] [9] . Recently, ABIN-1 was shown to mediate the recruitment of A20 to the IKK adaptor protein IKK␥, leading to the A20-mediated de-ubiquitination of IKK␥ and disruption of the NF-B activation signal [10] . In contrast to ABIN-1 and ABIN-2, which are constitutively expressed in several cell types, ABIN-3 expression is much more restricted. In this context, ABIN-3 was identified as an LPS-inducible gene in human monocytes, whose expression is regulated at the mRNA level [9] . More recently, ABIN-3 was also identified in a screen for IL-10-induced genes in LPS-stimulated macrophages, and was shown to be superinduced in response to IL-10 and different pro-inflammatory stimuli including TNF, LPS, IL-1, peptidoglycan, poly(I:C) and unmethylated CpG DNA [11] . Here [12] . The plasmid pconaLUC (LMBP 3248) [13] 
Given the essential role of NF-B-dependent gene expression in the regulation of innate and adaptive immune responses, it is not unexpected that unrestrained NF-B activation is associated with several inflammatory diseases such as Crohn's disease, asthma, rheumatoid arthritis and sepsis
Hence, several proteins act as checkpoints at different levels along the NF-B signalling pathway and apply various strategies to dampen NF-B activation, such as intervening with specific protein-protein interactions or specific posttranslational modifications of NF-B signalling proteins
. Many of these negative regulators are themselves regulated by NF-B and impose a negative feedback mechanism. For example, tumour necrosis factor (TNF) and lipopolysaccharide (LPS) strongly induce the NF-B-dependent expression of A20, which negatively regulates TNF-and LPS-induced NF-B activation by changing the ubiquitination status of specific NF-B signalling proteins [6]. A20-binding inhibitor of NF-B activation (ABIN)-1, ABIN-2 and ABIN-3 have been suggested to contribute to the NF-B inhibitory potential of A20
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ABIN-3 expression is increased by LPS and TNF, as well as during sepsis
ABIN-3 expression has previously been described as an LPS-inducible gene in the monocytic cell line THP-1 and in bone marrow-derived macrophages [9, 11] (Fig. 1B) . These data demonstrate that ABIN-3 expression is not restricted to LPS stimulated myeloid cells, but also occurs in other cell types in Fig. 1 ABIN-3 [19] . [20, 21] . The patients characteristics were the following: six patients with septic shock were studied; they were two males and four females with a mean age of 65 ± 3.5 years, a mean SAPS II score of 63 ± 6, and mean SOFA score 10.6 ± 0. 9 [22] . Interestingly, ABIN-3 expression in monocytes from the same patients was profoundly decreased 24 hrs after the onset of the corticotherapy, and came back to the levels found for healthy controls. In contrast, corticotherapy had no effect on the up-regulation of SIGIRR and MyD88s. (Fig. 1D) (Fig. 1D) , we could also demonstrate in these cells the (Fig. 1E) . [25] . Sc-514 is a selective IKK␤ inhibitor that binds specifically to the ATP-binding site of IKK␤ [26] . Fig. 2A and (Fig. 4) . Pre-incubation of the nuclear extract with anti-p65 specific antibodies before incubation with the 32 
expression is up-regulated in response to LPS and TNF. (A) Semi-quantitative RT-PCR of ABIN-3 mRNA expression in different cell lines. RNA was isolated from the indicated cell lines that were either left untreated or stimulated for 3 hrs with 100 ng/ml LPS or 1000 IU/ml TNF. Semi-quantitative RT-PCR was performed using ABIN-3 specific primers to amplify a 700 bp fragment of the ABIN-3 open-reading frame. ␤-actin was used as a control. (B) Western blotting for ABIN-3 protein expression in different cell lines. Cells were either left untreated or stimulated for 6 or 18 hrs with LPS or TNF as indicated. Cell extracts were separated by SDS-PAGE and analysed by Western blotting and immunodetection with anti-ABIN-3 polyclonal antibodies. ␤-actin expression was used as a control for equal loading. (C) Real-time quantitative PCR of ABIN-3 expression in monocytes from sepsis patients. Monocytes were selected by adherence from PBMC of healthy donors (n = 12) and septic shock patients (n = 6) before and 24 hrs after low-dose HC therapy. Total RNA was isolated and ABIN-3, SIGIRR and MyD88s expression were analysed by real time quantitative PCR using specific primers. All results were normalized with respect to the expression of GAPDH. *P<0.01 patients versus healthy controls (ANOVA), P<0.05 patients before HC versus patients after HC (Wilcoxon signed-rank test). (D) Effect of HC on LPSinduced ABIN-3 mRNA expression in primary human monocytes. Monocytes were selected by adherence from PBMC of healthy donors. Cells were stimulated with 100 ng/ml LPS for 20 hrs in the presence or the absence of 100 M HC, which was given 2 hrs after LPS. Total RNA was isolated and ABIN-3 mRNA expression was analysed by real-time PCR. Results were normalized with respect to the expression of GAPDH and represent the mean ± SD of three experiments performed on cells from different donors. (E) Protein expression of ABIN-3 in monocytes isolated from healthy donors. Cells were stimulated with 100 ng/ml LPS for 20 hrs in the presence or the absence of 100 M HC, which was given at the same time as LPS. Cell extracts were separated by SDS-PAGE and analysed by Western blotting and immunodetection with anti-ABIN-3 polyclonal antibodies. ␤-actin expression was used as a control
In addition, we also analysed ABIN-3, SIGIRR and MyD88s expression in monocytes from sepsis patients that had received low doses of hydrocortisone (HC) treatment, which is currently used for septic shock patients showing adrenal insufficiency
. The site of sepsis was pneumonia (n = 4), peritonitis (n = 1), and an endocarditis in the last case. Mean serum cortisol was 41 ± 10.5 µg/dl with only one responder defined as serum increase higher than 9 µg/dl after a corticotrophin test (250 µg bolus). This replacement therapy with low doses of corticosteroids was discontinuated later on. The patients were compared with 12 healthy controls (four males) with a mean age of 36±2 years. Similar to SIGIRR and MyD88s, ABIN-3 expression was significantly up-regulated in monocytes from sepsis patients before they received the low-dose corticotherapy. These results demonstrate the upregulation of multiple NF-B inhibitory proteins during sepsis, consistent with the previously described re-programming of monocytes to a hyporesponsive state during sepsis
To demonstrate that the inhibitory effect of HC on ABIN-3 expression was due to a direct effect on the monocytes, we also tested its effect on the LPSinduced expression of ABIN-3 mRNA in cultured primary monocytes from healthy patients
LPS-induced expression of ABIN-3 at the protein level, as well as its inhibition by HC treatment
NF-B inhibitors prevent the up-regulation of ABIN-3 in response to LPS
Because corticosteroids are known to negatively regulate NF-B activation [23], and because the pathophysiologic mechanism behind the clinical effects of corticosteroids in septic shock has been directly related to the inhibition of NF-B in PBMC [24], we hypothesized a role for NF-B in the regulation of ABIN-3 expression. To further investigate this, we tested the effect of pre-treatment of THP-1 cells with MG-132 and sc-514 on LPS-induced ABIN-3 mRNA and protein expression. MG-132 is a proteasome inhibitor that inhibits NF-B activation by preventing the proteasome-dependent degradation of IB␣, thereby preventing nuclear translocation of NF-B
Consistent with our previous observations, LPS clearly induced ABIN-3 mRNA and protein expression in THP-1 cells (
B). However, pretreatment of the cells with the NF-B inhibitors MG-132 and sc-514 significantly inhibited the effect of LPS, whereas no effect was observed when the cells were pre-treated with the solvent dimethyl sulfoxide (DMSO). Similar inhibitory effects were obtained when THP-1 cells were pre-treated with HC (data not shown), which is consistent with the results obtained in primary human monocytes (Fig. 1E). Altogether, these results indicate that the LPS-induced expression of ABIN-3 is NF-B dependent.
NF-B binding to the human ABIN-3 promoter
973). To investigate whether the predicted B binding element in the ABIN-3 promoter binds NF-B, we subjected nuclear extracts of LPS-and TNF-treated THP-1 cells to an electrophoretic mobility shift assay with respectively a wild type B (WT-B) and a mutant B (mut-B) oligonucleotide probe (B element GGGCCATCCC; mutated residues underlined) that were generated based on the predicted B binding sequence (GGGAAATCCC) of the ABIN-3 promoter. LPS and TNF both induced the rapid and sustained binding of NF-B to the WT-B probe, but not to the mut-B probe
P-labelled WT-B probe induced a supershift of the B-specific band, confirming the presence of p65 in the B element binding complex. Because the supershift was only partial, it is likely that other NF-B family members are also able to bind the B element in the ABIN-3 promoter. These results clearly illustrate the inducible binding of NF-B to the ABIN-3 promoter in response to LPS and TNF treatment of human monocytes.
The B element in the ABIN-3 promoter is functionally active
We showed above that ABIN-3 expression can be up-regulated by LPS and TNF in a NF-B dependent
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